SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001683168-17-000749
Filing Date
2017-03-31
Accepted
2017-03-31 17:07:47
Documents
83
Period of Report
2016-12-31

Document Format Files

Seq Description Document Type Size
1 FORM 10-K xenetic_10k-123116.htm 10-K 1197594
2 CERTIFICATION OF PRINCIPAL EXECUTIVE OFFICER xenetic_10k-ex3101.htm EX-31.1 9687
3 CERTIFICATION OF PRINCIPAL FINANCIAL OFFICER xenetic_10k-ex3102.htm EX-31.2 9614
4 CERTIFICATION xenetic_10k-ex3201.htm EX-32.1 4761
5 GRAPHIC image_001.jpg GRAPHIC 18850
  Complete submission text file 0001683168-17-000749.txt   5608209

Data Files

Seq Description Document Type Size
6 XBRL INSTANCE FILE xbio-20161231.xml EX-101.INS 938944
7 XBRL SCHEMA FILE xbio-20161231.xsd EX-101.SCH 54192
8 XBRL CALCULATION FILE xbio-20161231_cal.xml EX-101.CAL 68049
9 XBRL DEFINITION FILE xbio-20161231_def.xml EX-101.DEF 289310
10 XBRL LABEL FILE xbio-20161231_lab.xml EX-101.LAB 410052
11 XBRL PRESENTATION FILE xbio-20161231_pre.xml EX-101.PRE 382663
Mailing Address 99 HAYDEN AVENUE, SUITE 230 LEXINGTON MA 02421
Business Address 99 HAYDEN AVENUE, SUITE 230 LEXINGTON MA 02421 781-778-7720
Xenetic Biosciences, Inc. (Filer) CIK: 0001534525 (see all company filings)

IRS No.: 452952962 | State of Incorp.: NV | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 001-37937 | Film No.: 17731265
SIC: 2834 Pharmaceutical Preparations